HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 39 | 45 | 86.7% | |
| HF004 | 2020 | 61 | 69 | 88.4% | |
| HF006 | 2021 | 67 | 72 | 93.1% | |
| HF006 | 2022 | 68 | 72 | 94.4% | |
| HF006 | 2023 | 88 | 91 | 96.7% |
